Tongkat Ali for Testosterone (2026): What the Evidence Actually Shows

By Verified Supplement Data · Published March 16, 2026 · Sources: PubMed, NIH DSLD · Methodology · About Us

Comparison Table: Tongkat Ali Products by Cost Per Day

All products ranked by daily cost. Unlike magnesium or vitamin D, there is no single "clinical dose" for tongkat ali — trials have used 200-400mg of varying standardization levels. The key differentiator is eurycomanone content, which we note for each product.

Note: Unlike vitamins/minerals with standardized RDAs, tongkat ali products vary dramatically in standardization. A 100mg dose of 10% eurycomanone extract delivers more active compound than 1000mg of unstandardized root powder. Cost per day alone does not capture potency differences.

Clinical Evidence: Tongkat Ali and Testosterone

Systematic Review and Meta-Analysis (2022)

The strongest evidence comes from Leisegang et al. (2022), a systematic review and meta-analysis published in Medicina that examined 9 clinical studies on Eurycoma longifolia and testosterone (PMID: 36013514). Five RCTs were pooled in the meta-analysis.

Key findings:

• Significant increase in total testosterone: SMD = 1.352 (95% CI: 0.565–2.138, p = 0.001)
• The effect was confirmed in the hypogonadism subgroup — men with low-normal testosterone saw the most benefit
• Heterogeneity was high (I² = 90.1%), meaning results varied substantially across studies
• Study quality was mixed — several trials lacked proper blinding or used small samples

Our interpretation: The effect is real but modest. A standardized mean difference of 1.35 is statistically significant but does not mean your testosterone will increase 135%. In practical terms, expect a 10-15% increase in total testosterone if you start with low-normal levels and use a standardized extract.

Cortisol and Stress Reduction (Talbott 2013)

Talbott et al. (2013) conducted a randomized, double-blind, placebo-controlled trial in 63 moderately stressed adults (32 men, 31 women) using 200mg/day of standardized tongkat ali extract for 4 weeks (PMID: 23705671).

Results:

• Cortisol decreased 16% vs placebo
• Testosterone increased 37% vs placebo
• Tension reduced 11%, Anger reduced 12%, Confusion reduced 15% (Profile of Mood States)

Limitations: This was a 4-week study with 63 subjects — a moderate sample size. The 37% testosterone increase sounds dramatic but started from stressed individuals with suppressed testosterone. The real mechanism may be cortisol reduction allowing testosterone to normalize, not a direct androgenic effect.

Who It Actually Works For: Hypogonadal vs Normal Testosterone

This is the most important distinction that supplement marketers ignore.

Tambi et al. (2012) studied 76 men with late-onset hypogonadism who received 200mg/day of standardized tongkat ali extract for 1 month (PMID: 21671978). After treatment, 90.8% of patients showed normal testosterone values (up from baseline hypogonadal levels). The Aging Males' Symptoms (AMS) score also improved significantly.

A 6-month double-blind, placebo-controlled RCT (Firdaus et al., 2021) in 45 men with androgen deficiency of aging males (ADAM) found that 200mg/day of tongkat ali combined with concurrent training significantly improved erectile function and increased total testosterone (PMID: 33541567).

The pattern is clear: Tongkat ali helps men whose testosterone is below normal move back toward normal. It does not push already-normal testosterone above the physiological range. If you are a healthy 25-year-old man with testosterone of 600 ng/dL, do not expect tongkat ali to push you to 900. The evidence does not support that.

Fadogia Agrestis — The Huberman Effect

Fadogia agrestis became wildly popular after being recommended on the Huberman Lab podcast as a "testosterone booster." Here is the complete evidence base:

Study 1 (2005): Yakubu et al. gave aqueous fadogia stem extract to male rats at 18, 50, and 100 mg/kg for 5 days. Testosterone increased in a dose-dependent manner (PMID: 16281088). This is the study that launched a supplement industry.

Study 2 (2008): The same group (Yakubu et al.) followed up with a 28-day study at the same doses. At moderate and high doses, adverse effects on testicular function were observed (PMID: 18023305). Testicular histology showed dose-dependent changes. Recovery was partial at the lowest dose.

Study 3 (2009): Again the same group found that fadogia extract caused significant changes in liver and kidney enzyme markers at all tested doses over 28 days, with increased serum malondialdehyde (an oxidative stress marker) (PMID: 19755438).

The reality:

• Zero human clinical trials — not one
• All three studies are from the same research group in Nigeria using the same rat model
• The follow-up studies found testicular toxicity and liver/kidney changes
• No dose-translation studies to establish safe human doses have been conducted
• Rat-to-human dose extrapolation is notoriously unreliable (what works in rats often fails in humans, and what is safe in rats can be dangerous in humans)

Compare this to tongkat ali: 9+ human clinical trials, a systematic review and meta-analysis, EFSA safety evaluation, and studies lasting up to 6 months. The evidence gap is enormous. If you are taking fadogia agrestis, you are conducting an uncontrolled experiment on yourself with no human safety data.

What Tongkat Ali Does NOT Do

To be clear about the limitations of the evidence:

• It will not replace TRT. If you have clinically diagnosed hypogonadism requiring testosterone replacement therapy, tongkat ali is not a substitute. It may help men in the "gray zone" (low-normal T) but is not a replacement for medical treatment.
• It will not raise testosterone above your natural ceiling. Tongkat ali appears to help restore testosterone toward normal levels, not push it supraphysiological. It is not an anabolic steroid.
• It will not build muscle like steroids. Any testosterone increase from tongkat ali is too modest to produce steroid-like muscle gains. If a supplement company implies otherwise, they are lying.
• It will not work overnight. Studies showing benefits used 4-week to 6-month protocols. Single-dose effects have not been demonstrated.
• It may not work if your testosterone is already normal. The strongest evidence is in men with low-normal testosterone. Healthy young men with robust testosterone levels should not expect meaningful increases.

Product Deep Dives

Nootropics Depot Tongkat Ali 2% Eurycomanone — Best Value

At $0.25/day, this is the most cost-effective standardized tongkat ali available. Each capsule provides 200mg of extract standardized to 2% eurycomanone (4mg eurycomanone per capsule). Nootropics Depot uses HPTLC (High-Performance Thin-Layer Chromatography) testing to verify eurycomanone content — a meaningful quality control step that most brands skip. The 120-capsule bottle lasts 4 months at one capsule per day. This is the product we recommend for most people starting tongkat ali.

Nootropics Depot Tongkat Ali 10% Eurycomanone — Quality Pick

The highest-potency tongkat ali available at $0.65/day. Each capsule delivers 100mg of extract standardized to 10% eurycomanone (10mg eurycomanone per capsule) — 2.5x more active compound per capsule than the 2% version. HPTLC verified. The 120-capsule bottle lasts 4 months. Choose this if you have tried the 2% version and want to increase eurycomanone intake without taking multiple capsules, or if you prioritize potency over cost.

Double Wood Tongkat Ali 200:1 Extract — Budget Pick

At $0.37/day, Double Wood offers a 200:1 extract concentration ratio at 1000mg per 2-capsule serving. The caveat: "200:1" is a concentration ratio, not a standardization to eurycomanone content. You do not know how much eurycomanone is in each capsule. It is third-party tested for purity and contaminants, but the lack of eurycomanone standardization makes potency comparison difficult. This is a reasonable budget option if cost is your primary concern, but the Nootropics Depot 2% at $0.25/day is both cheaper and better standardized.

Momentous Tongkat Ali

At $0.67/day for 400mg of Indonesian-sourced root extract, Momentous carries Informed Sport Certified status — making it the only tongkat ali on our list suitable for competitive athletes subject to drug testing. However, it uses unstandardized root extract (not standardized to eurycomanone content), so actual active compound content is unknown. The Informed Sport certification is its primary value proposition. The 30-serving bottle is the smallest count, making the per-day cost the highest on this list.

How to Choose: Standardization > Dose > Brand

The single most important factor in choosing a tongkat ali supplement is eurycomanone standardization, not total milligrams.

Why standardization matters

Eurycomanone is the primary bioactive quassinoid in tongkat ali, believed to be responsible for its testosterone-supporting effects. Raw tongkat ali root contains roughly 0.2-1.5% eurycomanone naturally. Standardized extracts concentrate this:

• 10% eurycomanone — highest potency. 100mg extract = 10mg eurycomanone.
• 2% eurycomanone — good potency. 200mg extract = 4mg eurycomanone.
• "200:1" or "100:1" ratios — these describe concentration ratios, NOT eurycomanone content. A 200:1 extract means 200g of root was used to make 1g of extract, but the actual eurycomanone content is unspecified.
• Raw root powder — lowest and most variable potency. Eurycomanone content unknown.

Decision framework

1. Standardization: Choose products with a stated eurycomanone percentage. "200:1" and "100:1" are marketing terms, not standardization.
2. Dose: 200-400mg of standardized extract daily, matching clinical trial protocols.
3. Third-party testing: HPTLC verification of eurycomanone content. Informed Sport if you are a tested athlete.
4. Cost per day: After controlling for standardization, compare on daily cost.

Cycling Protocol

Most practitioners recommend cycling tongkat ali: 8 weeks on, 2 weeks off.

Why cycling matters:

• The longest RCT ran 6 months (PMID: 33541567) with no reported adverse events, but data beyond 6 months is scarce
• Tongkat ali may influence the hypothalamic-pituitary-gonadal (HPG) axis — cycling prevents potential receptor desensitization
• Cycling also provides a practical self-check: if you notice benefits disappear during the off-period, the supplement is likely doing something; if you notice no difference, reconsider whether it is worth continuing

Suggested schedule: Take daily for 8 weeks. Stop for 2 weeks. Resume. Take in the morning or early afternoon — tongkat ali can cause insomnia if taken in the evening.

Safety and Side Effects

What the safety data shows

EFSA (European Food Safety Authority) evaluated tongkat ali root extract and found no genotoxicity or acute toxicity concerns. The 6-month RCT (PMID: 33541567) reported no serious adverse events at 200mg/day.

Reported side effects

• Insomnia — the most commonly reported side effect, especially at higher doses or when taken late in the day. Take in the morning.
• Restlessness / irritability — occasionally reported, may relate to hormonal changes
• Increased body temperature — some users report feeling warmer
• GI discomfort — rare, usually resolves by taking with food

Who should NOT take tongkat ali

• Hormone-sensitive cancers: Prostate cancer, breast cancer, or any condition where testosterone modulation is contraindicated
• Pregnant or breastfeeding women: No safety data in these populations
• Children and adolescents: Not studied in developing individuals
• People on TRT or hormonal medications: Potential interactions with hormone therapy. Consult your endocrinologist.

Liver enzyme monitoring

While tongkat ali has not shown hepatotoxicity in clinical trials at standard doses, if you take it long-term, include liver enzymes (ALT, AST) in your regular bloodwork. This is standard precautionary advice for any herbal supplement taken chronically.

Frequently Asked Questions

Related Comparisons

• Ashwagandha Evidence Review — KSM-66 vs Sensoril, cortisol reduction, stress and anxiety evidence
• Anxiety + Sleep Stack — Magnesium glycinate + ashwagandha + L-theanine combination evidence

Sources